MoupaliDasMDMPH

Infectious Disease • Foster City, CA

HIV/AIDS Medicine

Executive Director, HIV and Emerging Viral Infections, Gilead Sciences

Join to view full profile

Dr. Das is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Das' full profile

Already have an account?

Office
333 Lakeside Drive
Foster City, CA 94404
Phone+1 650-522-4511

Education & Training

University of California (San Francisco)Fellowship, Infectious Disease, 2005 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
Columbia University Vagelos College of Physicians and SurgeonsClass of 2001

Certifications & Licensure

CA State Medical License 2005 - 2025

Clinical Trials

Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults Start of enrollment: 2014 Feb 25
Completed
Phase 3

Publications & Presentations

PubMed

3 citations
Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1...
Raphael J Landovitz, Li Tao, Juan Yang, Melanie de Boer, Christoph Carter
Clinical Infectious Diseases. 2024-11-22
1 citations
HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-lab...
David A Wohl, Christoph D Spinner, Jason Flamm, C Bradley Hare, Susanne Doblecki-Lewis
The Lancet. HIV. 2024-08-01
HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus Placebo.
Paul N Zivich, Stephen R Cole, Jessie K Edwards, David V Glidden, Moupali Das
The Journal of Infectious Diseases. 2024-04-12

Journal Articles

The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized HIV-Infected Patients in 11 U.S. Cities
Deborah K McMahon, Moupali Das, Wendy S Armstrong, Gregory M Lucas, Ank Nijhawan, Raul Mandler, Clinical Infectious Diseases

Lectures

7th International Conference on HIV Treatment & Prevention Adherence
International Association of Physicians in AIDS Care, Miami Beach, Florida - 6/3/2012

Press Mentions

Dr. Moupali Das, MD, MPH — Gilead Sciences — Dedicated to Ending the HIV EpidemicMarch 7th, 2023
HIV Capsid Inhibitor Offers New Option for People with Highly Resistant HIVMarch 10th, 2021
Weight Gain While on ART: Demographic, HIV and Treatment-Related FactorsOctober 29th, 2019
Join now to see all